Long-term use of SGLT2 inhibitors may prevent diabetic retinopathy progression in diabetes patients

Taiwan: A recent study in Scientific Reports has revealed that co-administration of metformin and sodium-glucose co-transporter 2 (SGLT2) inhibitors delays the progression of diabetic retinopathy (DR)...

Related Keywords

Taiwan ,China ,Chun Ju Lin ,School Of Medicine ,China Medical University ,Scientific Reports ,Odium Glucose Co Transporter 2 Inhibitors ,Diabetic Retinopathy ,Metformin ,Type 2 Diabetes ,Progression ,Sglt2 Inhibitor ,Diabetes ,Nti Diabetic Medications ,Add On Therapy ,Blindness ,